IT1406221B1 - COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD - Google Patents
COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELDInfo
- Publication number
- IT1406221B1 IT1406221B1 ITRM2010A000650A ITRM20100650A IT1406221B1 IT 1406221 B1 IT1406221 B1 IT 1406221B1 IT RM2010A000650 A ITRM2010A000650 A IT RM2010A000650A IT RM20100650 A ITRM20100650 A IT RM20100650A IT 1406221 B1 IT1406221 B1 IT 1406221B1
- Authority
- IT
- Italy
- Prior art keywords
- triptofano
- aspartico
- nad
- nutritional
- vitamin
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000002537 cosmetic Substances 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 229940016667 resveratrol Drugs 0.000 title 1
- 235000021283 resveratrol Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000650A IT1406221B1 (en) | 2010-12-13 | 2010-12-13 | COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD |
| PCT/IB2011/055642 WO2012080952A1 (en) | 2010-12-13 | 2011-12-13 | Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields |
| EP11813401.4A EP2651406A1 (en) | 2010-12-13 | 2011-12-13 | Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000650A IT1406221B1 (en) | 2010-12-13 | 2010-12-13 | COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITRM20100650A1 ITRM20100650A1 (en) | 2012-06-14 |
| IT1406221B1 true IT1406221B1 (en) | 2014-02-14 |
Family
ID=43737282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM2010A000650A IT1406221B1 (en) | 2010-12-13 | 2010-12-13 | COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2651406A1 (en) |
| IT (1) | IT1406221B1 (en) |
| WO (1) | WO2012080952A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3765010A2 (en) * | 2018-03-13 | 2021-01-20 | Nuchido Limited | Treatment of diseases involving nad |
| WO2020230011A1 (en) * | 2019-05-13 | 2020-11-19 | Guglielmo Buonamici | Human nutraceutical supplement |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2567848A1 (en) * | 2004-06-04 | 2006-01-05 | Washington University | Methods and compositions for treating neuropathies |
| KR20110044291A (en) * | 2008-08-12 | 2011-04-28 | 서트리스 파마슈티컬즈, 인코포레이티드 | Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
-
2010
- 2010-12-13 IT ITRM2010A000650A patent/IT1406221B1/en active
-
2011
- 2011-12-13 WO PCT/IB2011/055642 patent/WO2012080952A1/en unknown
- 2011-12-13 EP EP11813401.4A patent/EP2651406A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2651406A1 (en) | 2013-10-23 |
| WO2012080952A1 (en) | 2012-06-21 |
| ITRM20100650A1 (en) | 2012-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181364T1 (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
| IL221160A (en) | 1,2,4-triazine-3-amine derivatives, process for the preparation thereof and use thereof in the preparation of medicaments | |
| IL222268A (en) | Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments | |
| HK1219055A1 (en) | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof q10 (coq10) | |
| IL231536A (en) | Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases | |
| HK1243630A1 (en) | Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use | |
| MX338515B (en) | Tetrahydroquinoline derivatives useful as bromodomain inhibitors. | |
| PL2731947T3 (en) | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes | |
| EP2931288A4 (en) | Topical formulations for increasing the dermal concentration of hyaluronic acid | |
| IL218113A0 (en) | Stable liquid oily ready-to-use formulations, preparation thereof and use thereof | |
| IL232325A0 (en) | 18-methyl-6'7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis | |
| ZA201206360B (en) | Solid composition for the oral administration of dyes and diagnostic use thereof | |
| HK1203947A1 (en) | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions (halofuginol) | |
| IL218137A (en) | Derivatives of substituted 4-benzoamido benzoic acid, compositions comprising them and their use in the manufacture of medicaments | |
| LT2400943T (en) | Cosmetic or pharmaceutical emulsion for the skin to be mixed just prior to use | |
| SG10201704712QA (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| IL226003A0 (en) | Trans-2-decenoic acid derivative and pharmaceutical agent containing the same | |
| EP2822561A4 (en) | Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof | |
| HK1123998A1 (en) | Pharmaceutical preparation containing garcinia acid and use thereof | |
| BR112012016736A2 (en) | composition, pharmaceutical formulation and use of composition " | |
| IT1406221B1 (en) | COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD | |
| HK1214771A1 (en) | Formulations for use in the treatment of skin conditions | |
| IL222642A0 (en) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males | |
| HU1000352D0 (en) | Salts of (di)nitroindoline derivatives and preparation and use thereof and compositions containing the same |